Pierre Bastid

About Pierre Bastid

Pierre Bastid is a French industrial executive and investor best known for his governance role in listed technology and life-sciences companies. He is currently most notably the Chairman of the Board of CARMAT, a position he has held since June 2024 after serving as a director of the company since 2018. He became deeply involved in CARMAT well before that appointment: through the LOHAS and Les Bastidons entities he controls, he was one of the company’s significant shareholders, and he subscribed to each capital increase carried out by CARMAT since 2016. That long-term commitment made him a key governance and financing stakeholder around the development of the Aeson® artificial heart. His professional background is rooted in senior industrial leadership. According to CARMAT’s governance materials, Bastid spent more than 25 years in executive positions at major international groups including Schlumberger, Schneider Electric, Valeo and Thomson. He also served as President and CEO of Converteam Group, where he helped scale the business before selling it to General Electric, reportedly after substantially increasing its value. Regulatory filings also show that he served on the boards of Cellectis and Pharnext, underscoring a broader portfolio of mandates in biotechnology and high-growth companies. Bastid’s expertise lies in industrial transformation, corporate strategy, capital allocation, and governance in complex situations. At CARMAT, his role has been associated with board leadership, support for financing rounds, and backing the company’s commercial development agenda. His profile combines operational experience with investor discipline, which is particularly relevant for innovative companies navigating scale-up, funding, and market execution challenges. In French listed-company terms, he stands out as a hands-on governance professional with a track record in restructuring, growth, and value creation across industrial and life-sciences environments.